Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine

BACKGROUND: The novel antidepressant agomelatine, a melatonergic MT(1)/MT(2) agonist combined with 5-HT(2c) serotonin antagonist properties, showed antidepressant action in preclinical and clinical studies. There is a general agreement that the therapeutic action of antidepressants needs the activat...

Descripción completa

Detalles Bibliográficos
Autores principales: Musazzi, Laura, Seguini, Mara, Mallei, Alessandra, Treccani, Giulia, Pelizzari, Mariagrazia, Tornese, Paolo, Racagni, Giorgio, Tardito, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207903/
https://www.ncbi.nlm.nih.gov/pubmed/25332063
http://dx.doi.org/10.1186/s12868-014-0119-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207903/
https://www.ncbi.nlm.nih.gov/pubmed/25332063
http://dx.doi.org/10.1186/s12868-014-0119-1

Ejemplares similares